Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -82,751 | -64,960 | -39,153 | -12,614 | -30,781 |
| Depreciation Amortization | 3,510 | 2,876 | 2,025 | 1,003 | 3,818 |
| Accounts receivable | -2,232 | -360 | -1,756 | -2,766 | -3,536 |
| Accounts payable and accrued liabilities | 2,377 | 2,387 | -1,884 | -253 | 3,567 |
| Other Working Capital | 354 | 5,824 | 2,790 | -2,033 | -1,092 |
| Other Operating Activity | 8,096 | 3,604 | 6,374 | 3,691 | 2,157 |
| Operating Cash Flow | $-70,646 | $-50,629 | $-31,604 | $-12,972 | $-25,867 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -15,272 | -16,398 | -38,232 | -33,730 | 3,000 |
| PPE Investments | -3,550 | -3,135 | -2,653 | -718 | -1,023 |
| Purchase Sale Intangibles | -500 | -625 | -607 | -500 | N/A |
| Other Investing Activity | -500 | -625 | -607 | -500 | 0 |
| Investing Cash Flow | $-19,322 | $-20,158 | $-41,492 | $-34,948 | $1,977 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 58,419 | 58,419 | 58,420 | N/A | 10,000 |
| Debt Repayment | -35,229 | -34,919 | -34,214 | -452 | -1,654 |
| Common Stock Issued | 13 | 13 | 13 | N/A | 93,135 |
| Common Stock Repurchased | -61 | N/A | N/A | N/A | -171 |
| Other Financing Activity | 415 | 0 | 0 | 1 | 0 |
| Financing Cash Flow | $23,557 | $23,513 | $24,219 | $-451 | $101,310 |
| Beginning Cash Position | 90,763 | 90,763 | 90,763 | 90,763 | 13,343 |
| End Cash Position | 24,352 | 43,489 | 41,886 | 42,392 | 90,763 |
| Net Cash Flow | $-66,411 | $-47,274 | $-48,877 | $-48,371 | $77,420 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,646 | -50,629 | -31,604 | -12,972 | -25,867 |
| Capital Expenditure | -3,550 | -3,135 | -2,653 | -718 | -1,023 |
| Free Cash Flow | -74,196 | -53,764 | -34,257 | -13,690 | -26,890 |